Join us on our mission to make personalized medicine available to all. At PubGene AS, we are building Coremine Vitae, a new Digital Health solution… Read More »Senior Front-end or Full-Stack Developer
Dr. Jimita Toraskar from PubGene AS was invited to participate in the International Lecture Series organized by Dr. Bhanuben Nanavati College of Pharmacy in Mumbai,… Read More »Why Google, When You Can Coremine – Lecture by Jimita Toraskar
The futureofhealth.care is an online discussion platform for healthcare professionals. It identifies white space in the market so that promising start-up and healthcare industry can… Read More »Dr. Jimita Toraskar interviewed by The Future of Health.care group
PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical Devices Directive – 93/42/EEC MDD and subsequent amendments.
Innovation Norway – the State and the county authorities’ instrument for achieving value-creating business development – has allocated pre-project funds to PubGene to investigate how COREMINE Medical can be used to… Read More »Pre-study on the use of COREMINE™ Medical AS decision support for Covid-19
PubGene has had dialogue with Norwegian health authorities on a possible role for establishing an information channel on the COVID-19 virus, with continuous update on… Read More »Dialogue with Norwegian health authorities on COVID-19
PubGene’s project proposal ‘Coremine Vitae: Realising the promise of precision medicine for cancer patients and their healthcare providers with biomedical intelligence reporting’ submitted for the European Innovation Council… Read More »PubGene received the Horizon 2020 Seal of Excellence
PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs.